S'abonner

Patient Acceptance of Rapid HIV Testing Practices in an Urban Emergency Department: Assessment of the 2006 CDC Recommendations for HIV Screening in Health Care Settings - 20/08/11

Doi : 10.1016/j.annemergmed.2007.10.028 
Jason S. Haukoos, MD, MSc a, b, c, , Emily Hopkins, MSPH a, Richard L. Byyny, MD, MSc a

Denver Emergency Department HIV Testing Study Group

a Department of Emergency Medicine, Denver Health Medical Center, Denver, CO 
b Department of Preventive Medicine and Biometrics, University of Colorado, Denver School of Medicine, Denver, CO 
c Department of Integrative Physiology, University of Colorado at Boulder, Boulder, CO. 

Address for correspondence: Jason S. Haukoos, MD, MSc, Department of Emergency Medicine, Denver Health Medical Center, 777 Bannock Street, Mail Code 0108, Denver, CO 80204; 303-436-7141, fax 303-436-7541

Résumé

Study objective

The Centers for Disease Control and Prevention (CDC) recently released revised recommendations for HIV testing in health care settings, calling for the performance of nontargeted opt-out HIV screening, the integration of informed consent for HIV testing into the general consent for medical care, and the uncoupling of prevention counseling and testing. It is unclear, however, whether patients will understand opt-out screening or be satisfied with integration of the consent for HIV testing into the general medical consent or the uncoupling of counseling from testing. The objective of this study is to evaluate patients’ acceptance of the CDC’s revised recommendations in an urban emergency department (ED).

Methods

This was a cross-sectional survey study performed in the ED of an urban, public safety net hospital. The approximate annual ED census is 55,000 patients, and an approximate undiagnosed HIV seroprevalence ranges from 0.7% to 2.2%. A standardized survey instrument was developed and piloted and was then implemented with trained research assistants. Adult patients who were awake, alert, and agreed to participate in the study were included.

Results

During the 3-month study period, 529 patients were enrolled. The median age was 38 years (interquartile range 27 to 49 years; range 18 to 87 years), 57% were men, 48% were white, 28% were Hispanic, 18% were black, and 6% represented another race or ethnicity. When patients were asked whether they would have been tested had opt-out methodology been used, 81% (95% confidence interval [CI] 77% to 84%) would have agreed to be tested. When asked whether they would have been tested had opt-in methodology been used, there was no difference (absolute difference 0%; 95% CI –5% to 4%). However, explanation of opt-out screening was required for 11% (95% CI 8% to 14%), whereas explanation of opt-in screening was required for only 2% (95% CI 1% to 4%) (absolute difference 9%; 95% CI 5% to 11%). When asked whether the patient’s physician recommended an HIV test during the ED visit, 93% (95% CI 91% to 95%) would have agreed to be tested. When asked whether consent for HIV testing should be separate from consent for general emergency medical care, 50% (95% CI 46% to 54%) agreed. When asked whether counseling was necessary before performing an HIV test, 34% (95% CI 30% to 38%) agreed, and when asked whether counseling was necessary after receiving a negative HIV test result, 35% (95% CI 31% to 40%) agreed.

Conclusion

A large proportion of ED patients appear willing to be screened for HIV infection in accordance with the CDC’s revised recommendations for HIV testing in health care settings. Similar proportions were willing to be tested when opt-out or opt-in screening strategies were used; however, a significantly greater proportion required explanation of opt-out screening.

Le texte complet de cet article est disponible en PDF.

Plan


 Supervising editor: Gregory J. Moran, MD
 Author contributions: JSH, EH, and RLB conceived the study. JSH obtained funding. JSH and EH supervised the conduct of the study and data collection. EH managed the data and JSH conducted all statistical analyses. JSH drafted the article, and all authors contributed substantially to its revision. JSH takes responsibility for the paper as a whole.
 Funding and support: By Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article, that might create any potential conflict of interest. See the Manuscript Submission Agreement in this issue for examples of specific conflicts covered by this statement. Supported, in part, by a grant from the Centers for Disease Control and Prevention (U18 PS000314) and an unrestricted grant from Abbott Laboratories. The CDC or Abbott Laboratories did not participate in the design, execution, or reporting of results from this study. Funding was received by JSH.
 Publication dates: Available online January 11, 2008.
 Reprints not available from the authors.


© 2008  American College of Emergency Physicians. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 51 - N° 3

P. 303 - mars 2008 Retour au numéro
Article précédent Article précédent
  • MRSA: Deadly Super Bug or Just Another Staph?
  • David A. Talan
| Article suivant Article suivant
  • Correction

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.